017180.KS
MYUNGMOON Pharm co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 1,250.00
−1.42%Margins
Gross margin
57.3%
EBITDA margin
2.3%
EBIT margin
0.8%
Net margin
-0.8%
FCF margin
-5.0%
-1.7%
Return on equity
-0.6%
Return on assets
0.8%
Return on invested capital
0.70x
Asset turnover
-KRW 3.6B
Cash from operations
KRW 716
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026